Cumberland Pharmaceuticals Inc.
Ifetroban Treatment for Systemic Sclerosis

Abstract:

The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.